# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-25-001205
Filing Date
2025-04-04
Accepted
2025-04-04 17:17:33
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | zk2532902.htm iXBRL | 20-F | 2464277
2 | EXHIBIT 1.1 | exhibit_1-1.htm | EX-1.1 | 225328
3 | EXHIBIT 11.1 | exhibit_11-1.htm | EX-11.1 | 88007
4 | EXHIBIT | exhibit_12-1.htm | EX-12.1 | 7692
5 | EXHIBIT 12.2 | exhibit_12-2.htm | EX-12.2 | 7909
6 | EXHIBIT 13.1 | exhibit_13-1.htm | EX-13.1 | 4473
7 | EXHIBIT 13.2 | exhibit_13-2.htm | EX-13.2 | 4484
8 | EXHIBIT 15.1 | exhibit_15-1.htm | EX-15.1 | 3236
14 | GRAPHIC | image0.jpg | GRAPHIC | 180218
15 | GRAPHIC | image00001.jpg | GRAPHIC | 2732
16 | GRAPHIC | image00029.jpg | GRAPHIC | 39621
17 | GRAPHIC | image00030.jpg | GRAPHIC | 20949
18 | GRAPHIC | image00031.jpg | GRAPHIC | 29573
19 | GRAPHIC | image00032.jpg | GRAPHIC | 24129
20 | GRAPHIC | image00033.jpg | GRAPHIC | 31175
21 | GRAPHIC | image00034.jpg | GRAPHIC | 44121
22 | GRAPHIC | image00035.jpg | GRAPHIC | 30357
23 | GRAPHIC | image00036.jpg | GRAPHIC | 64682
24 | GRAPHIC | image00037.jpg | GRAPHIC | 48570
25 | GRAPHIC | image00019.jpg | GRAPHIC | 46974
26 | GRAPHIC | image00020.jpg | GRAPHIC | 31952
27 | GRAPHIC | image00021.jpg | GRAPHIC | 44477
28 | GRAPHIC | image00022.jpg | GRAPHIC | 36035
29 | GRAPHIC | image00023.jpg | GRAPHIC | 40105
30 | GRAPHIC | image00024.jpg | GRAPHIC | 31014
31 | GRAPHIC | image00027.jpg | GRAPHIC | 33584
32 | GRAPHIC | image00028.jpg | GRAPHIC | 17365
33 | GRAPHIC | image5.jpg | GRAPHIC | 520860
34 | GRAPHIC | image00002.jpg | GRAPHIC | 33267
| Complete submission text file | 0001178913-25-001205.txt |  | 12230555

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | cmmb-20241231.xsd | EX-101.SCH | 58039
10 | XBRL CALCULATION FILE | cmmb-20241231_cal.xml | EX-101.CAL | 43501
11 | XBRL DEFINITION FILE | cmmb-20241231_def.xml | EX-101.DEF | 130188
12 | XBRL LABEL FILE | cmmb-20241231_lab.xml | EX-101.LAB | 535277
13 | XBRL PRESENTATION FILE | cmmb-20241231_pre.xml | EX-101.PRE | 267399
102 | EXTRACTED XBRL INSTANCE DOCUMENT | zk2532902_htm.xml | XML | 1319543

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38807 | Film No.: 25815796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)